Related Experiment Video
Updated: Feb 17, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Predicting Neonatal Hyperbilirubinemia Using First Day Serum Bilirubin Level in Late Preterm and Term Healthy Newborn
1Dr Md Kamrul Ahsan Khan, Assistant Professor (Neonatology), Department of Pediatrics, Sheikh Sayera Khatun Medical College, Gopalgonj, Bangladesh.
Insights
A day 1 total serum bilirubin (TSB) level of 5.65mg/dl can predict significant hyperbilirubinemia in newborns. This screening test helps identify infants needing closer follow-up to prevent complications.
Area of Science:
- Neonatology
- Pediatric Medicine
- Public Health
Background:
- Neonatal hyperbilirubinemia is a frequent cause of hospital readmission for healthy term and late preterm infants.
- Early discharge policies and limited follow-up in developing nations necessitate predictive tools for managing neonatal jaundice.
- Effective prediction of hyperbilirubinemia is crucial for timely intervention and prevention of complications.
Purpose of the Study:
- To evaluate the predictive value of day 1 total serum bilirubin (TSB) levels for significant hyperbilirubinemia in newborns.
- To determine the optimal cutoff value of day 1 TSB for identifying neonates at risk.
- To aid in the early management and prevention of complications associated with neonatal jaundice.
Main Methods:
- An observational analytical study involving 100 healthy late preterm and term neonates.
- Measurement of day 1 total serum bilirubin (TSB) levels.
- Receiver Operating Characteristic (ROC) analysis to identify the best predictive cutoff value for significant hyperbilirubinemia (defined as TSB ≥17mg/dl after 72 hours).
Main Results:
- A total of 89 neonates were analyzed, with 15.74% developing significant hyperbilirubinemia.
- Mean day 1 TSB was significantly higher in neonates who developed hyperbilirubinemia (5.97±1.74mg/dl) compared to those who did not (3.19±1.4mg/dl).
- A day 1 TSB level of ≥5.65mg/dl demonstrated high sensitivity (86%) and specificity (91%) for predicting significant hyperbilirubinemia (AUC-0.880, p=0.001), with a negative predictive value of 97%.
Conclusions:
- Day 1 total serum bilirubin level is a reliable predictor of subsequent significant hyperbilirubinemia in late preterm and term neonates.
- A day 1 TSB cutoff of 5.65mg/dl is recommended for identifying infants requiring close follow-up.
- Strict monitoring of infants with a day 1 TSB ≥5.65mg/dl is essential for early detection and management of neonatal jaundice.
Abstract:
Hyperbilirubinemia is a common problem during the neonatal period and is the most common reason for readmission after early hospital discharge of the healthy near term and term infants. This early discharge policy along with limited follow-up facilities in developing countries and inadequate communication between physicians and parents necessitates a prognostic test to predict hyperbilirubinemia in these newborns; for early and effective management and prevention of potential complication before it occurred. This observational analytical study was done to determine the predictability of day1 total serum bilirubin (TSB) level as a screening test and identify the best cutoff value which would predict neonates likely to develop significant hyperbilirubinemia. The study was carried out in the Department of Neonatology and Department of Gynecology and Obstetrics, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh from 1st April 2013 to 31st March 2014. A TSB level of ≥17mg/dl after 72 hours was defined as significant hyperbilirubinemia. By purposive sampling method, 100 healthy late preterm and term neonates fulfilling the inclusion criteria were enrolled and 89 were finally analyzed. Among 89 neonates 14(15.74%) developed significant hyperbilirubinemia (Group II) and 75(84.26%) did not develop hyperbilirubinemia (Group I). Mean time of sample collection was similar in both groups. Mean TSB level on day1 was significantly higher in Group II (5.97±1.74mg/dl) than Group I (3.19±1.4mg/dl). By using ROC (Receiver Operating Characteristic) analysis, TSB level of 5.65mg/dl on day 1 has the best combination of sensitivity (86%) and specificity (91%) to predict neonates at risk of significant hyperbilirubinemia (AUC-0.880, p=0.001). At this cut-off PPV was 63% and NPV 97%. Total serum bilirubin level on first day of life predicts neonates at risk of subsequent significant hyperbilirubinemia and late preterm and term babies with TSB level of ≥5.65mg/dl on day 1 of life should be followed up strictly either in the hospital or in the outpatient department on day 5.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

